August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Nirmit Kumar: Excellent debate on the benefit of chemo in premenopausal patients with RS ≤ 25
Mar 11, 2025, 13:39

Nirmit Kumar: Excellent debate on the benefit of chemo in premenopausal patients with RS ≤ 25

Nirmit Kumar, Senior Global Medical Strategy Leader at AstraZeneca, shared a post on X:

“Excellent debate on the benefit of chemo in premenopausal patients with Recurrence Score (RS) ≤ 25 between Sara Tolaney and Kevin Kalinsky.

Tolerability of ovarian function suppression varies so adjuvant chemotherapy usually recommended depending on patient’s clinical profile.”

Nirmit Kumar: Excellent debate on the benefit of chemo in premenopausal patients with RS ≤ 25